쎌바이오텍 분기보고서 (2020.09)
1. 요약재무정보

가. 요약연결재무정보[단위:원]

구 분	제 26기	제 25기	제 24기

(2020년9월말)	(2019년12월말)	(2018년12월말)

[유동자산]	67,189,332,128	69,257,564,281	81,046,650,905

·현금및현금성자산	13,074,124,504	9,422,378,167	13,341,941,419

·매출채권및기타유동채권	5,206,219,072	5,494,880,004	15,095,056,221

·단기금융상품(금융상품자산)	15,058,540,852	25,388,057,537	35,278,174,907

·기타유동금융자산(투자자산)	29,568,337,093	24,413,273,736	13,545,647,368

·재고자산	3,408,833,449	3,076,168,462	2,388,363,540

·반품자산	37,410,234	33,872,237	40,302,227

·기타유동자산	835,845,844	361,466,198	1,355,788,043

·당기법인세자산	21,080	1,067,467,940	1,377,180

[비유동자산]	40,301,920,734	39,045,870,509	31,000,757,142

·장기매출채권및기타비유동채권	632,464,579	697,272,032	733,499,425

·장기금융상품	2,000,000	2,000,000	2,000,000

·유형자산	37,156,519,072	36,065,257,416	28,651,687,912

·영업권 이외의 무형자산	1,856,291,986	1,701,887,732	1,108,153,146

·이연법인세자산	654,645,097	579,453,329	505,416,659

자 산 총 계	107,491,252,862	108,303,434,790	112,047,408,047

[유동부채]	5,831,561,774	4,188,957,486	6,401,568,685

[비유동부채]	857,912,830	512,083,963	20,952,000

부 채 총 계	6,689,474,604	4,701,041,449	6,422,520,685

[지배기업 소유주지분]	100,801,778,258	103,602,393,341	105,624,887,362

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(20,181,944,695)	(17,654,758,745)	(12,933,848,295)

[기타포괄손익누계액]	(594,314,807)	(50,468,305)	(20,191,531)

[이익잉여금]	104,118,283,666	103,847,866,297	101,119,173,094

자 본 총 계	100,801,778,258	103,602,393,341	105,624,887,362

기 간	(2020.01.01~	(2019.01.01~	(2018.01.01~

2020.09.30)	2019.12.31)	2018.12.31)

매출액	34,661,618,037	45,959,677,976	62,543,665,262

영업이익	2,488,939,262	5,794,686,592	21,674,843,695

당기순이익	4,611,206,769	7,231,093,203	19,384,224,065

지배기업 소유주지분	4,611,206,769	7,231,093,203	19,384,224,065

비지배지분	-	-	-

주당순이익	650	976	2,583

연결에포함된회사수	4	4	4

나.요약별도재무정보 [단위:원]

구 분	제 26기	제 25기	제 24기

(2020년9월말)	(2019년12월말)	(2018년12월말)

[유동자산]	66,412,553,052	70,042,220,949	81,551,406,381

·현금및현금성자산	10,392,237,043	7,925,181,737	6,645,441,928

·매출채권및기타유동채권	7,715,413,486	8,270,344,721	22,667,250,501

·단기금융상품(금융상품자산)	15,058,540,852	25,388,057,537	35,278,174,907

·기타유동금융자산(투자자산)	29,568,337,093	24,413,273,736	13,433,570,354

·재고자산	2,879,234,388	2,682,413,489	2,212,138,854

·반품자산	37,410,234	33,872,237	40,302,227

·기타유동자산	761,379,956	262,397,082	1,274,527,610

·당기법인세자산	-	1,066,680,410	-

[비유동자산]	44,395,895,200	42,090,502,230	33,628,024,131

·장기매출채권및기타비유동채권	203,940,411	253,940,411	287,668,411

·장기금융상품(금융상품자산)	2,000,000	2,000,000	2,000,000

·기타비유동금융자산(투자자산)	-	-	-

·종속기업에 대한 투자자산	7,533,507,020	6,134,357,020	4,802,157,020

·유형자산	34,956,112,842	34,102,999,369	27,433,217,993

·영업권 이외의 무형자산	1,395,991,494	1,292,861,997	875,084,785

·이연법인세자산	304,343,433	304,343,433	227,895,922

자 산 총 계	110,808,448,252	112,132,723,179	115,179,430,512

[유동부채]	4,329,552,665	3,176,703,689	5,840,431,073

[비유동부채]	206,581,522	5,000,000	25,952,000

부 채 총 계	4,536,134,187	3,181,703,689	5,866,383,073

[자본금]	4,700,000,000	4,700,000,000	4,700,000,000

[자본잉여금]	12,759,754,094	12,759,754,094	12,759,754,094

[자본조정]	(20,178,757,695)	(17,651,571,745)	(12,930,661,295)

[기타포괄손익누계액]	(628,231,002)	(39,540,756)	(14,048,417)

[이익잉여금]	109,619,548,668	109,182,377,897	104,798,003,057

자 본 총 계	106,272,314,065	108,951,019,490	109,313,047,439

종속ㆍ관계ㆍ공동기업 투자주식의 평가방법	원가법	원가법	원가법

기 간	(2020.01.01~	(2019.01.01~	(2018.01.01~

2020.09.30)	2019.12.31)	2018.12.31)

매출액	33,010,960,464	44,005,368,232	60,466,044,745

영업이익	2,660,814,332	7,295,863,355	22,816,115,717

당기순이익	4,777,960,171	8,886,774,840	20,530,424,708

주당순이익	673	1,199	2,736